申请人:Aebi Johannes
公开号:US20090048238A1
公开(公告)日:2009-02-19
The invention is concerned with novel biaryl derivatives of formula (I),
wherein
m, R
1
, R
2
, R
3
, X
1
, X
2
and X
3
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
这项发明涉及式(I)的新型联苯衍生物,其中m、R1、R2、R3、X1、X2和X3如描述和权利要求中所定义,并且其生理上可接受的盐。这些化合物是CCR-2受体、CCR-5受体和/或CCR-3受体的拮抗剂,可用作药物。